江苏南京：链接全球资本！宁企赴港上市热潮涌动

Core Viewpoint - A significant wave of companies from Nanjing is pursuing IPOs in Hong Kong, contributing to a broader trend of increased overseas listings by Chinese firms in 2023, with 60 companies listed on the Hong Kong Stock Exchange and a financing share of 58.9% from the exchange [1][10]. Group 1: Nanjing Companies Going Public - Four companies from Nanjing successfully listed this year, including Jiangsu Aisidun Automation Co., which leads the industrial robot market with a 10.5% market share [2][4]. - Thirteen Nanjing enterprises have submitted applications to the Hong Kong Stock Exchange, indicating a strong interest in international capital markets [7][10]. Group 2: Innovative Pharmaceutical Companies - Nanjing's innovative pharmaceutical companies are particularly active, with Jiangsu Aisidun and Weili Zhibo both successfully listing on the Hong Kong Stock Exchange within a month [8][9]. - The Nanjing Jiangbei New Area has implemented supportive policies to facilitate the overseas listing of innovative drug companies, including a 1 billion yuan investment fund [10][11]. Group 3: Market Dynamics and Trends - The trend of Nanjing companies going public is driven by both the unique advantages of the Hong Kong market and the urgent financing needs of enterprises, particularly in emerging sectors like biomedicine and artificial intelligence [11][12]. - The Hong Kong Stock Exchange has optimized its listing system, providing broader capital access for companies at different development stages, which is attracting more firms to consider overseas listings [12].